Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.4 GBX
Updated:
May 14, 2024
Fusion Antibodies PLC
Common Shares Outstanding
|
Fusion Antibodies PLC
Common Shares Outstanding Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Common Shares Outstanding
£59.5m
|
CAGR 3-Years
33%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Common Shares Outstanding
£859.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Common Shares Outstanding
£671m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Common Shares Outstanding
£84.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Common Shares Outstanding
£50.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Common Shares Outstanding
£680.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
57%
|
CAGR 10-Years
42%
|
See Also
What is Fusion Antibodies PLC's Common Shares Outstanding?
Common Shares Outstanding
59.5m
GBP
59.5m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Common Shares Outstanding amounts to 59.5m GBP.
What is Fusion Antibodies PLC's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
22%
22%
Over the last year, the Common Shares Outstanding growth was 129%. The average annual Common Shares Outstanding growth rates for Fusion Antibodies PLC have been 33% over the past three years , 22% over the past five years .
You don't have any saved screeners yet
